Inactive Instrument

Insiders Akcea Therapeutics, Inc.

Equities

AKCA

US00972L1070

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Aspen Neuroscience, Inc. Appoints Lisa Johnson-Pratt as Senior Vice President, Therapeutic Program Lead	Feb. 14	CI
Mersana Therapeutics, Inc. Announces Carla Poulson as Chief Human Resources Officer	21-01-19	CI
Akcea Therapeutics, Inc. Announces Management Changes	20-10-13	CI
Akcea Therapeutics, Inc. Appoints Christophe Hotermans as Senior Vice President of Global Medical Affairs	20-07-20	CI
Akcea Therapeutics, Inc. Appoints William Andrews as Chief Medical Officer	20-07-09	CI
Akcea Therapeutics, Inc. Appoints Tracy Palmer Berns as Chief Compliance Officer	20-06-29	CI
Akcea Therapeutics, Inc. Announces Resignation of Louis St. L. O'Dea as Chief Medical Officer, Effective July 7, 2020	20-06-19	CI
Akcea Appoints Kia Motesharei as New Senior Vice President, Business Development and Corporate Strategy	20-06-09	CI
Akcea Therapeutics, Inc. Appoints Michael D. Price as Executive Vice President and Chief Financial Officer	20-05-18	CI
Akcea Therapeutics Appoints Carla Poulson as Senior Vice President and Chief Human Resources Officer	20-05-07	CI
Akcea Therapeutics, Inc. Appoints Robert Dolski as Principal Financial and Accounting Officer	20-04-29	CI
Akcea Therapeutics Announces Appointment of Dr. Damien McDevitt as CEO	20-03-24	CI
Akcea Therapeutics, Inc Announces Executive Changes	20-03-11	CI
Akcea Therapeutics, Inc. Expands Board of Directors with Appointment of Dr. Amber Salzman	20-02-13	CI
Akcea Therapeutics, Inc. Announces Resignation of Michael Maclean as Chief Financial Officer, Effective April 1, 2020	20-01-06	CI
Akcea Therapeutics, Inc. Announces Management Changes	19-12-16	CI
Akcea Therapeutics, Inc. Names Alex Howarth as Chief Operating Officer	19-12-04	CI
Akcea Therapeutics, Inc. Promotes Kyle Jenne to Chief Commercial Officer	19-10-23	CI
Akcea Therapeutics, Inc. Announces Management Changes	19-09-23	CI
Akcea Therapeutics, Inc. Announces Changes to Board of Directors	18-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Akcea Therapeutics, Inc.

Equities

AKCA

US00972L1070

Insiders

Filters